164 related articles for article (PubMed ID: 3311054)
1. Effect of bezafibrate and colestyramine in patients with primary hypercholesterolemia.
Steinhagen-Thiessen E; Müller S; Holler HD; Lang PD
Arzneimittelforschung; 1987 Jun; 37(6):726-8. PubMed ID: 3311054
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of a combined bezafibrate retard-colestyramine treatment in patients with hypercholesterolemia.
Fischer S; Hanefeld M; Lang PD; Fücker K; Bergmann S; Gehrisch S; Leonhardt W; Jaross W
Arzneimittelforschung; 1990 Apr; 40(4):469-72. PubMed ID: 2192717
[TBL] [Abstract][Full Text] [Related]
3. Effects of bezafibrate and gemfibrozil on serum lipoproteins in primary hypercholesterolemia.
Weisweiler P
Arzneimittelforschung; 1988 Jul; 38(7):925-7. PubMed ID: 3207437
[TBL] [Abstract][Full Text] [Related]
4. [Effectiveness, tolerance and safety of simvastatin in comparison with bezafibrate in treatment of hypercholesterolemia].
Lechleitner M; Sailer S; Irsigler H; Klein W; Patsch JR
Wien Med Wochenschr; 1995; 145(21):577-83. PubMed ID: 8560901
[TBL] [Abstract][Full Text] [Related]
5. Comparative study of a microporous cholestyramine analogue (filicol) and gemfibrozil for treatment of severe primary hypercholesterolemia. Short- and long-term results.
Ros E; Zambón D; Bertomeu A; Cusó E; Sanllehy C; Casals E
Arch Intern Med; 1991 Feb; 151(2):301-5. PubMed ID: 1992957
[TBL] [Abstract][Full Text] [Related]
6. Probucol and cholestyramine combination in the treatment of severe hypercholesterolemia.
Sommariva D; Bonfiglioli D; Tirrito M; Pogliaghi I; Branchi A; Cabrini E
Int J Clin Pharmacol Ther Toxicol; 1986 Sep; 24(9):505-10. PubMed ID: 3781686
[TBL] [Abstract][Full Text] [Related]
7. [The comparative treatment with lovastatin and bezafibrate of primary hypercholesterolemia. A randomized and double-blind trial].
Sánchez Domínguez J; Rodríguez Padial L; Navarro A; Barcina C; Fernández E; Rivera G; Cuesta L; Lázaro-Carrasco E
Rev Esp Cardiol; 1991 Apr; 44(4):251-7. PubMed ID: 2068368
[TBL] [Abstract][Full Text] [Related]
8. Comparative efficacy and safety of pravastatin and cholestyramine alone and combined in patients with hypercholesterolemia. Pravastatin Multicenter Study Group II.
Arch Intern Med; 1993 Jun; 153(11):1321-9. PubMed ID: 8507122
[TBL] [Abstract][Full Text] [Related]
9. [Effects of bezafibrate on lipoprotein lipids and apolipoproteins B and A1 in patients with primary hypercholesterolemia].
Branchi A; Sommariva D; Tirrito M; Bonfiglioli D; Pini C; Scandiani L; Orlandi S; Fasoli A
Clin Ter; 1987 Jul; 122(1):17-23. PubMed ID: 2973892
[No Abstract] [Full Text] [Related]
10. Fluvastatin in combination with other lipid-lowering agents.
Jokubaitis LA
Br J Clin Pract Suppl; 1994 Dec; (77):28-32. PubMed ID: 19496270
[TBL] [Abstract][Full Text] [Related]
11. Fluvastatin in combination with other lipid-lowering agents.
Jokubaitis LA
Br J Clin Pract Suppl; 1996 Jan; 77A():28-32. PubMed ID: 8729588
[TBL] [Abstract][Full Text] [Related]
12. [Effect of bezafibrate in isolated hypercholesterolemia and mixed hyperlipidemia on infarct risk (Stepwise Program for Individual Risk Identification and Therapy): an open multicenter study].
Sinzinger H; Virgolini I; Kudlacek P
Wien Klin Wochenschr; 1991; 103(13):381-7. PubMed ID: 1897230
[TBL] [Abstract][Full Text] [Related]
13. Long-term treatment of severe familial hypercholesterolemia in children: effect of sitosterol and bezafibrate.
Becker M; Staab D; Von Bergman K
Pediatrics; 1992 Jan; 89(1):138-42. PubMed ID: 1727999
[TBL] [Abstract][Full Text] [Related]
14. Relation of clinical benefit of raising high-density lipoprotein cholesterol to serum levels of low-density lipoprotein cholesterol in patients with coronary heart disease (from the Bezafibrate Infarction Prevention Trial).
Goldenberg I; Benderly M; Sidi R; Boyko V; Tenenbaum A; Tanne D; Behar S
Am J Cardiol; 2009 Jan; 103(1):41-5. PubMed ID: 19101227
[TBL] [Abstract][Full Text] [Related]
15. Treatment of severe, resistant familial combined hyperlipidemia with a bezafibrate-lovastatin combination.
Yeshurun D; Abukarshin R; Elias N; Lanir A; Naschitz JE
Clin Ther; 1993; 15(2):355-63. PubMed ID: 8519043
[TBL] [Abstract][Full Text] [Related]
16. Lovastatin versus bezafibrate for hyperlipemia treatment after heart transplantation.
Hidalgo L; Zambrana JL; Blanco-Molina A; López-Granados A; Concha M; Casares J; Jiménez-Pérez J; López-Miranda J; Pérez-Jiménez F
J Heart Lung Transplant; 1995; 14(3):461-7. PubMed ID: 7654731
[TBL] [Abstract][Full Text] [Related]
17. Effect of combined therapy with bezafibrate and cholestyramine on low-density lipoprotein metabolism in type IIa hypercholesterolemia.
Series JJ; Caslake MJ; Kilday C; Cruickshank A; Demant T; Lorimer AR; Packard CJ; Shepherd J
Metabolism; 1989 Feb; 38(2):153-8. PubMed ID: 2643751
[TBL] [Abstract][Full Text] [Related]
18. A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance.
Sasaki J; Ikeda Y; Kuribayashi T; Kajiwara K; Biro S; Yamamoto K; Ageta M; Kobori S; Saikawa T; Otonari T; Kono S
Clin Ther; 2008 Jun; 30(6):1089-101. PubMed ID: 18640465
[TBL] [Abstract][Full Text] [Related]
19. [Multicenter comparative study on safety, tolerance, and effectiveness of lovastatin combined or not with cholestyramine, and gemfibrozil combined or not with cholestyramine in the treatment of primary hypercholesterolemia].
Jover E; Aranda JL; Nogués X; del Palacio A; Rubiés-Prat J
Med Clin (Barc); 1996 May; 106(20):776-9. PubMed ID: 8801396
[TBL] [Abstract][Full Text] [Related]
20. Long-term effects of bezafibrate and of a bezafibrate and cholestyramine combination on lipids and lipoprotein lipids in type IIa hypercholesterolaemic patients.
Sommariva D; Tirrito M; Bonfiglioli D; Pogliaghi I; Branchi A; Cabrini E
Int J Clin Pharmacol Res; 1986; 6(3):249-53. PubMed ID: 3744628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
